Evaluating serum CXCL12, sCD22, Lp-PLA2 levels and ratios as biomarkers for diagnosis of Alzheimer's disease

doi:10.5498/wjp.v14.i3.380

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1934)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

HTML

776

Figures (1-2)

152

Tables (1-4)

143

Sum=1142

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

129

Download

316

Sum=445

Publishing Process of This Article

Item

Count

Browse

Download

224

Sum=301

Mar 19, 2024 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Psychiatry. Mar 19, 2024; 14(3): 380-387
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.380

Full Size Figure Download Figure

Figure 2 Peripheral blood biomarker profiles and diagnostic potential in Alzheimer's disease. A: The concentrations of Lp-PLA2, sCD22, and CXCL12 in the peripheral blood of healthy individuals and patients with Alzheimer's disease (AD); B: Comparison of Lp-PLA2/sCD22 and CXCL12/sCD22 ratios in healthy individuals and patients with AD; C: receiver operating characteristic curves for the diagnosis of AD using Lp-PLA2, sCD22, CXCL12, Lp-PLA2/sCD22, and CXCL12/sCD22. AUC: Area under the curve; ROC: Receiver operating characteristic.

Citation: Liu ZL, Hua FF, Qu L, Yan N, Zhang HF. Evaluating serum CXCL12, sCD22, Lp-PLA2 levels and ratios as biomarkers for diagnosis of Alzheimer's disease. World J Psychiatry 2024; 14(3): 380-387
URL: https://www.wjgnet.com/2220-3206/full/v14/i3/380.htm
DOI: https://dx.doi.org/10.5498/wjp.v14.i3.380